Purpose: To evaluate efficacy and safety of the iStent inject combined with phacoemulsification in Asian eyes with normal-tension glaucoma (NTG) up to 12 months after surgery.
Study Design: Retrospective case series.
Methods: Retrospective case series of eyes undergoing surgery from April 2017 to August 2019.